Used in organic synthesis as a building block for pharmaceuticals, particularly in Suzuki-Miyaura cross-coupling reactions to form biaryl compounds. Its boronic acid group enables efficient carbon-carbon bond formation, making it valuable in drug discovery and development. Commonly applied in the preparation of kinase inhibitors and other bioactive molecules targeting central nervous system disorders and inflammatory diseases. The trifluoroethoxy group enhances metabolic stability and lipophilicity, improving drug candidate pharmacokinetics.